WHO ICTRP trial
The impact of magnesium sulfate on early postoperative cognitive dysfunction in…
ChiCTR2400092987 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400092987 |
|---|---|
| Public title | The impact of magnesium sulfate on early postoperative cognitive dysfunction in elderly patients undergoing laparoscopic colorectal cancer surgery: A double-blind, placebo-controlled, randomized controlled trial |
| Scientific title | The impact of magnesium sulfate on early postoperative cognitive dysfunction in elderly patients undergoing laparoscopic colorectal cancer surgery: A double-blind, placebo-controlled, randomized controlled trial |
| Primary sponsor | the Affiliated Hospital of Jiangnan University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Postoperative Cognitive Dysfunction |
| Interventions | Magnesium sulfate group:Intraoperative infusion of magnesium sulfate;Control group:Intraoperative infusion of saline |
| Registration date | Nov 26, 2024 |
| Target size | Magnesium sulfate group:59;Control group:59 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: